Rationales for drug development in inflammation: eicosanoids and oxygen-derived free radicals.
Ahnfelt-Rønne
I
I
Department of Pharmacology, Leo Pharmaceutical Products, Ballerup.
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology; D015777:Eicosanoids / Q000378:metabolism / Q000502:physiology*; D005609:Free Radicals; D006801:Humans; D007249:Inflammation / Q000276:immunology / Q000503:physiopathology*; D011448:Prostaglandin Antagonists / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D015777:Eicosanoids; D005609:Free Radicals; D011448:Prostaglandin Antagonists